CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) today announced that Stephen J. Tulipano, CPA, Chief Financial Officer, will present at the Fifth Annual Think Equity Partners Growth Conference in the Conservatory of St. Regis Hotel, in San Francisco, CA, on Wednesday, September 19, 2007, 10:30 a.m. PDT.
Mr. Tulipano will provide a general overview of the Company and discuss the progress of Javelin’s three late stage pain care drug candidates Dyloject™, PMI-150 and Rylomine™ being developed in the US and Europe.
